# HEALTH DATA ANALYSIS REPORT 2024

**Há» tÃªn:** Nguyá»…n Anh ThÃ¡i
**NÄƒm sinh:** 1991 (33 tuá»•i)
**Nguá»“n dá»¯ liá»‡u:**
1.  [cite_start]Jio Health (Máº«u A: 05/05/2023) [cite: 7]
2.  [cite_start]Jio Health (Máº«u B: 09/11/2024) [cite: 114]
3.  [cite_start]Diag Center (Máº«u C - Tinh dá»‹ch Ä‘á»“: 09/10/2024) [cite: 67]

---

## 1. EXECUTIVE SUMMARY (TL;DR)
* **Tá»•ng quan:** Thá»ƒ tráº¡ng tá»‘t, chá»©c nÄƒng sinh sáº£n **xuáº¥t sáº¯c**. Tuy nhiÃªn, há»‡ thá»‘ng chuyá»ƒn hÃ³a Ä‘ang gáº·p váº¥n Ä‘á» nghiÃªm trá»ng vá»›i viá»‡c Ä‘Ã o tháº£i Acid Uric.
* **Cáº£nh bÃ¡o Ä‘á» (Critical):** Acid Uric mÃ¡u tÄƒng cao (Nguy cÆ¡ Gout/Sá»i tháº­n) vÃ  DÆ°Æ¡ng tÃ­nh vi khuáº©n HP dáº¡ dÃ y.
* **Xu hÆ°á»›ng (Trend):** Chá»©c nÄƒng tháº­n (eGFR) Ä‘ang cÃ³ xu hÆ°á»›ng giáº£m nháº¹ (-13%) sau 18 thÃ¡ng do gÃ¡nh náº·ng lá»c Acid Uric.
* **Äiá»ƒm sÃ¡ng (Positive):** ÄÃ£ cÃ³ miá»…n dá»‹ch ViÃªm gan B vÃ  men gan Ä‘Ã£ há»“i phá»¥c vá» má»©c bÃ¬nh thÆ°á»ng.

---

## 2. PHÃ‚N TÃCH CHI TIáº¾T (DETAILED ANALYSIS)

### A. Sá»©c Khá»e Sinh Sáº£n (Reproductive Health)
*Dá»¯ liá»‡u: Diag Center (10/2024)*

**ÄÃ¡nh giÃ¡: XUáº¤T Sáº®C (Excellent)**
CÃ¡c chá»‰ sá»‘ Ä‘á»u vÆ°á»£t xa tiÃªu chuáº©n WHO 2010. Há»‡ thá»‘ng "sáº£n xuáº¥t" hoáº¡t Ä‘á»™ng hiá»‡u suáº¥t cao.

| Metric (Chá»‰ sá»‘) | Káº¿t quáº£ | Tham chiáº¿u (Min) | ÄÃ¡nh giÃ¡ |
| :--- | :--- | :--- | :--- |
| **Thá»ƒ tÃ­ch (Volume)** | **3 mL** | $\ge 1.5$ mL | [cite_start]Tá»‘t [cite: 70] |
| **Tá»•ng sá»‘ lÆ°á»£ng (Total Count)** | **306 M** | $\ge 39$ M | [cite_start]**Cao gáº¥p ~8 láº§n chuáº©n** [cite: 87] |
| **Äá»™ di Ä‘á»™ng (Total Motility)** | **54%** | $\ge 42$% | [cite_start]Hiá»‡u quáº£ cao [cite: 70] |
| **HÃ¬nh dáº¡ng bÃ¬nh thÆ°á»ng** | **9%** | $\ge 4$% | [cite_start]Cháº¥t lÆ°á»£ng gen tá»‘t [cite: 70] |

### B. Chuyá»ƒn HÃ³a & Ná»™i Táº¡ng (Metabolic & Organ Function)
*So sÃ¡nh: Jio Health 2023 vs 2024 (Delta 18 thÃ¡ng)*

#### ğŸ”´ Cáº£nh BÃ¡o (Warning)
1.  **Acid Uric (Gout Risk):**
    * [cite_start]2023: 489 $\mu$mol/L [cite: 25]
    * [cite_start]2024: **555 $\mu$mol/L** [cite: 125]
    * *Delta:* $\uparrow$ **+13.5%** (VÆ°á»£t ngÆ°á»¡ng an toÃ n 200-420).
    * *Insight:* Ná»“ng Ä‘á»™ ráº¥t cao, nguy cÆ¡ káº¿t tá»§a tinh thá»ƒ táº¡i khá»›p vÃ  tháº­n.
2.  **Dáº¡ dÃ y (Infection):**
    * [cite_start]H.Pylori IgG: **Positive (>8.00)**[cite: 133].
    * *Insight:* Äang nhiá»…m khuáº©n HP, nguy cÆ¡ viÃªm loÃ©t dáº¡ dÃ y tÃ¡ trÃ ng.

#### ğŸŸ¡ Cáº§n Theo DÃµi (Monitoring)
1.  **Chá»©c nÄƒng Tháº­n (Kidney Function):**
    * [cite_start]eGFR: Giáº£m tá»« **105** (2023) $\rightarrow$ **91** (2024) mL/min[cite: 25, 125].
    * [cite_start]Creatinine: TÄƒng tá»« **79** $\rightarrow$ **88.6** $\mu$mol/L[cite: 19, 125].
    * *Insight:* Tuy váº«n trong ngÆ°á»¡ng bÃ¬nh thÆ°á»ng, nhÆ°ng xu hÆ°á»›ng giáº£m lá»c cho tháº¥y tháº­n Ä‘ang chá»‹u Ã¡p lá»±c (kháº£ nÄƒng cao do pháº£i lá»c lÆ°á»£ng lá»›n Acid Uric).

#### ğŸŸ¢ TÃ­ch Cá»±c (Positive)
1.  **Miá»…n dá»‹ch ViÃªm gan B:**
    * [cite_start]HbsAb: TÄƒng tá»« **<2.00** (2023) $\rightarrow$ **97.10** (2024)[cite: 28, 133].
    * *Insight:* ÄÃ£ cÃ³ khÃ¡ng thá»ƒ báº£o vá»‡ máº¡nh máº½.
2.  **Men Gan (Liver Enzymes):**
    * [cite_start]ALT: Giáº£m tá»« **50.9** (2023) $\rightarrow$ **40.0** (2024)[cite: 19, 131].
    * *Insight:* Gan Ä‘Ã£ giáº£m tá»•n thÆ°Æ¡ng, hoáº¡t Ä‘á»™ng á»•n Ä‘á»‹nh.
3.  **Má»¡ MÃ¡u (Lipid Profile):**
    * [cite_start]Cholesterol, Triglyceride, LDL Ä‘á»u trong ngÆ°á»¡ng an toÃ n[cite: 131].

---

## 3. Káº¾ HOáº CH HÃ€NH Äá»˜NG (ACTION PLAN)

Ãp dá»¥ng tÆ° duy quáº£n trá»‹ rá»§i ro (Risk Management):

### Phase 1: Xá»­ lÃ½ Khá»§ng hoáº£ng (Immediate Action)
* **Má»¥c tiÃªu:** ÄÆ°a Acid Uric < 420 vÃ  diá»‡t trá»« HP.
* **HÃ nh Ä‘á»™ng:**
    * [ ] **KhÃ¡m chuyÃªn khoa:** TiÃªu hÃ³a (Ä‘á»ƒ láº¥y thuá»‘c diá»‡t HP) vÃ  CÆ¡ xÆ°Æ¡ng khá»›p (Ä‘á»ƒ láº¥y thuá»‘c háº¡ Acid Uric).
    * [ ] **Input Control:** Cáº¯t giáº£m tá»‘i Ä‘a Ä‘áº¡m Ä‘á» (bÃ², chÃ³), ná»™i táº¡ng vÃ  rÆ°á»£u bia trong 3 thÃ¡ng tá»›i.

### Phase 2: Tá»‘i Æ°u hÃ³a váº­n hÃ nh (Optimization)
* **Má»¥c tiÃªu:** Phá»¥c há»“i eGFR lÃªn >100.
* **HÃ nh Ä‘á»™ng:**
    * [ ] **TÄƒng Throughput:** Uá»‘ng Ä‘á»§ 2.5 - 3.0 lÃ­t nÆ°á»›c/ngÃ y Ä‘á»ƒ tÄƒng tá»‘c Ä‘á»™ lá»c cáº§u tháº­n.
    * [ ] **Monitoring:** XÃ©t nghiá»‡m láº¡i Acid Uric vÃ  Creatinine sau 3 thÃ¡ng.

---
*Report generated on: 2025-11-20 based on provided medical records.*
